A New Jersey Superior Court jury yesterday found Swiss drug maker Roche Holding AG failed to adequately warn a patient of the bowel disease risks associated with its acne medicine Accutane and awarded him $2. Alabama computer manager Andrew McCarrell, 36, said he had undergone multiple surgeries, including having his colon removed, after taking the drug in 1995. Roche denied the drug caused the disease and said there was no scientific evidence linking the two. The trial was the first of about 400 U. Great home delivery subscription deals here! read more

Technorati Tags: drug, disease, roche, 1995, 2, 36, acne news

ATLANTIC CITY, New Jersey (Reuters) - A New Jersey jury on Tuesday found that Swiss drugmaker Roche Holding AG failed to adequately warn a patient of the bowel disease risks associated with its acne medicine Accutane and awarded him $2. The jury, during its third day of deliberations, also found that the failure to warn was a major contributing cause of his contracting the bowel disease and awarded the plaintiff an additional $119,000 to cover medical expenses. However, in considering New Jersey state consumer fraud charges, the jury in New Jersey Superior Court found for Roche, saying the company did not misrepresent or conceal Accutane's bowel risks prior to June 1995. McCarrell, who has three children aged between 10 months and 7 years, said after the verdict that he will now be able to afford better medical treatment and to take time off from work, unpaid if necessary, to deal with his condition. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. read more

Technorati Tags: jersey, reuters, bowel, found, jury, 1995, acne news

US Venture Partners and Latterell Venture Partners led the round, joining current investors De Novo Ventures and Palo Alto Healthcare in the financing of Talima. Onychomycosis is often treated with a combination of modalities to shorten the duration of systemic drug use, and to minimize the risk of adverse effects of oral terbinafine (brand name Lamisil®). Venture Partners (USVP) is a leading Silicon Valley-based venture capital firm dedicated to helping entrepreneurs build world-class companies that are leaders in their markets. Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. read more

Technorati Tags: talima, company, partners, systemic, venture, dermatology, acne news